Acrokeratosis verruciformis

Last updated
Acrokeratosis verruciformis
Other namesAcrokeratosis verruciformis of Hopf [1]
Autosomal dominant - en.svg
Acrokeratosis verruciformis has an autosomal dominant pattern of inheritance
Specialty Medical genetics   OOjs UI icon edit-ltr-progressive.svg

Acrokeratosis verruciformis is a rare autosomal dominant disorder appearing at birth or in early childhood, characterized by skin lesions that are small, verrucous, flat papules resembling warts along with palmoplantar punctate keratoses and pits. [2] [3] However sporadic forms, whose less than 10 cases have been reported, presents at a later age, usually after the first decade and generally lack palmoplantar keratoses. Whether acrokeratosis verruciformis and Darier disease are related or distinct entities has been controversial, like Darier's disease, it is associated with defects in the ATP2A2 gene. [4] however the specific mutations found in the ATP2A2 gene in acrokeratosis verruciformis have never been found in Darier's disease. [5]

Contents

Signs and symptoms

Clinical signs of acrokeratosis include verrucous plaques and flat-topped, polygonal papules. [6] The lesions range in hue from brown to skin tone, and their friction might cause vesicles. [4] [7] The backs of the hands and feet's proximal and distal interphalangeal joints are typically where the lesions are seen. [8] Lesions are less common and only occasionally seen on other body parts. [9] The frontal scalp, flexures, and oral mucosa are not affected by the condition. [10] On the palms and soles, punctate keratosis is another symptom of the illness. [6] Changes to the nails, such as thickening of the nail plate, leukonychia, longitudinal ridges, and nicks in the free edges, are often noted. [8]

Causes

Acrokeratosis verruciformis is caused by mutations in the ATP2A2 gene and is inherited in an autosomal dominant fashion. [11]

Diagnosis

The diagnosis is established by histological characteristics such as acanthosis, hyperkeratosis, hypergranulosis without parakeratosis, and papillomatosis, which are limited epidermal elevations referred to as "church spires." [6]

Treatment

Superficial ablation is currently the only effective treatment available. [9]

See also

Related Research Articles

<span class="mw-page-title-main">Skin condition</span> Any medical condition that affects the integumentary system

A skin condition, also known as cutaneous condition, is any medical condition that affects the integumentary system—the organ system that encloses the body and includes skin, nails, and related muscle and glands. The major function of this system is as a barrier against the external environment.

<span class="mw-page-title-main">Keratin 16</span> Protein-coding gene in the species Homo sapiens

Keratin 16 is a protein that in humans is encoded by the KRT16 gene.

<span class="mw-page-title-main">Darier's disease</span> Medical condition

Darier's disease (DAR) is a rare, inherited skin disorder that presents with multiple greasy, crusting, thick brown bumps that merge into patches. It is an autosomal dominant disorder discovered by French dermatologist Ferdinand-Jean Darier.

<span class="mw-page-title-main">Seborrheic keratosis</span> Skin disease

A seborrheic keratosis is a non-cancerous (benign) skin tumour that originates from cells, namely keratinocytes, in the outer layer of the skin called the epidermis. Like liver spots, seborrheic keratoses are seen more often as people age.

<span class="mw-page-title-main">Actinic keratosis</span> Skin disorder

Actinic keratosis (AK), sometimes called solar keratosis or senile keratosis, is a pre-cancerous area of thick, scaly, or crusty skin. Actinic keratosis is a disorder of epidermal keratinocytes that is induced by ultraviolet (UV) light exposure. These growths are more common in fair-skinned people and those who are frequently in the sun. They are believed to form when skin gets damaged by UV radiation from the sun or indoor tanning beds, usually over the course of decades. Given their pre-cancerous nature, if left untreated, they may turn into a type of skin cancer called squamous cell carcinoma. Untreated lesions have up to a 20% risk of progression to squamous cell carcinoma, so treatment by a dermatologist is recommended.

<span class="mw-page-title-main">Palmoplantar keratoderma</span> Medical condition

Palmoplantar keratodermas are a heterogeneous group of disorders characterized by abnormal thickening of the stratum corneum of the palms and soles.

<span class="mw-page-title-main">Meleda disease</span> Medical condition

Meleda disease (MDM) or "mal de Meleda", also called Mljet disease, keratosis palmoplantaris and transgradiens of Siemens, is an extremely rare autosomal recessive congenital skin disorder in which dry, thick patches of skin develop on the soles of the hands and feet, a condition known as palmoplantar hyperkeratosis. Meleda Disease is a skin condition which usually can be identified not long after birth. This is a genetic condition but it is very rare. The hands and feet usually are the first to show signs of the disease but the disease can advance to other parts of the body. Signs of the disease include thickening of the skin, on hands and soles of feet, which can turn red in color. There currently is no cure and treatment is limited, but Acitretin can be used in severe cases.

<span class="mw-page-title-main">Epidermodysplasia verruciformis</span> Medical condition

Epidermodysplasia verruciformis (EV) is a skin condition characterised by warty skin lesions. It results from an abnormal susceptibility to HPV infection (HPV) and is associated with a high lifetime risk of squamous cell carcinomas in skin. It generally presents with scaly spots and small bumps particularly on the hands, feet, face and neck; typically beginning in childhood or in a young adult. The bumps tend to be flat, grow in number and then merge to form plaques. On the trunk, it typically appears like pityriasis versicolor; lesions there being slightly scaly and tan, brown, red or looking pale. On the elbows, it may appear like psoriasis. On the forehead, neck and trunk, the lesions may appear like seborrheic keratosis.

ATP2A2 also known as sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) is an ATPase associated with Darier's disease and Acrokeratosis verruciformis.

Florid cutaneous papillomatosis (FCP), is an obligate paraneoplastic syndrome.

<span class="mw-page-title-main">Urbach–Wiethe disease</span> Rare recessive genetic disorder

Urbach–Wiethe disease is a very rare recessive genetic disorder, with approximately 400 reported cases since its discovery. It was first officially reported in 1929 by Erich Urbach and Camillo Wiethe, although cases may be recognized dating back as early as 1908.

<span class="mw-page-title-main">Acrokeratoelastoidosis of Costa</span> Medical condition

Acrokeratoelastoidosis of Costa or Acrokeratoelastoidosis is a hereditary form of marginal keratoderma, and can be defined as a palmoplantar keratoderma. It is distinguished by tiny, firm pearly or warty papules on the sides of the hands and, occasionally, the feet. It is less common than the hereditary type of marginal keratoderma, keratoelastoidosis marginalis.

<span class="mw-page-title-main">Porokeratosis</span> Medical condition

Porokeratosis is a specific disorder of keratinization that is characterized histologically by the presence of a cornoid lamella, a thin column of closely stacked, parakeratotic cells extending through the stratum corneum with a thin or absent granular layer.

<span class="mw-page-title-main">Inflammatory linear verrucous epidermal nevus</span> Medical condition

Inflammatory Linear Verrucous Epidermal Nevus is a rare disease of the skin that presents as multiple, discrete, red papules that tend to coalesce into linear plaques that follow the Lines of Blaschko. The plaques can be slightly warty (psoriaform) or scaly (eczema-like). ILVEN is caused by somatic mutations that result in genetic mosaicism. There is no cure, but different medical treatments can alleviate the symptoms.

Actinic granuloma (AG) was first described by O'Brien in 1975 as a rare granulomatous disease. Lesions appear on sun-exposed areas, usually on the face, neck, and scalp, with a slight preference for middle-aged women. They are typically asymptomatic, single or multiple, annular or polycyclic lesions measuring up to 6 cm in diameter, with slow centrifugal expansion, an erythematous elevated edge, and a hypopigmented, atrophic center.

Granuloma multiforme is a cutaneous condition most commonly seen in central Africa, and rarely elsewhere, characterized by skin lesions that are on the upper trunk and arms in sun-exposed areas. It may be confused with tuberculoid leprosy, with which it has clinical similarities. The condition was first noted by Gosset in the 1940s, but it was not until 1964 that Leiker coined the term to describe "a disease resembling leprosy" in his study in Nigeria.

Progressive nodular histiocytosis is a cutaneous condition clinically characterized by the development of two types of skin lesions: superficial papules and deeper larger subcutaneous nodules. Progressive nodular histiocytosis was first reported in 1978 by Taunton et al. It is a subclass of non-Langerhans cell histiocytosis and a subgroup of xanthogranuloma.

<span class="mw-page-title-main">Bowenoid papulosis</span> Medical condition

Bowenoid papulosis is a cutaneous condition characterized by the presence of pigmented verrucous papules on the body of the penis. They are associated with human papillomavirus, the causative agent of genital warts. The lesions have a typical dysplastic histology and are generally considered benign, although a small percentage will develop malignant characteristics.

Howel–Evans syndrome is an extremely rare condition involving thickening of the skin in the palms of the hands and the soles of the feet (hyperkeratosis). This familial disease is associated with a high lifetime risk of esophageal cancer. For this reason, it is sometimes known as tylosis with oesophageal cancer (TOC).

References

  1. Rapini RP, Bolognia JL, Jorizzo JL (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN   978-1-4160-2999-1.
  2. Freedberg IM, Eisen IZ, Wolff K, Austen F, Goldsmith LA, Katz S (2003). Fitzpatrick's Dermatology in General Medicine (6th ed.). New York: McGraw-Hill, Medical Pub. Division. ISBN   978-0-07-138076-8.
  3. James WD, Berger T, Elston D (2006). Andrews' Diseases of the Skin : Clinical Dermatology (10th ed.). Philadelphia: Saunders Elsevier. ISBN   978-0-7216-2921-6.
  4. 1 2 Dhitavat J, Macfarlane S, Dode L, Leslie N, Sakuntabhai A, MacSween R, et al. (February 2003). "Acrokeratosis verruciformis of Hopf is caused by mutation in ATP2A2: evidence that it is allelic to Darier's disease". The Journal of Investigative Dermatology. 120 (2): 229–232. doi: 10.1046/j.1523-1747.2003.t01-1-12045.x . PMID   12542527.
  5. Gupta A, Sharma YK, Vellarikkal SK, Jayarajan R, Dixit V, Verma A, et al. (April 2016). "Whole-exome sequencing solves diagnostic dilemma in a rare case of sporadic acrokeratosis verruciformis". Journal of the European Academy of Dermatology and Venereology. 30 (4): 695–697. doi: 10.1111/jdv.12983 . PMID   25622760. S2CID   35181817.
  6. 1 2 3 Andrade, Tatiana Cristina Pedro Cordeiro de; Silva, Gardênia Viana da; Silva, Tatiane Meira Pinho; Pinto, Ana Cecília Versiani Duarte; Nunes, Adauto José Ferreira; Martelli, Antônio Carlos Ceribelli (2016). "Acrokeratosis verruciformis of Hopf — Case report". Anais Brasileiros de Dermatologia. FapUNIFESP (SciELO). 91 (5): 639–641. doi:10.1590/abd1806-4841.20164919. ISSN   0365-0596. PMC   5087224 . PMID   27828639.
  7. Serarslan, Gamze; Di˙dar Balci, Di˙dem; Homan, Seydo (2007-01-01). "Acitretin treatment in acrokeratosis verruciformis of Hopf". Journal of Dermatological Treatment. Informa UK Limited. 18 (2): 123–125. doi:10.1080/09546630601121029. ISSN   0954-6634. PMID   17520472. S2CID   21336730.
  8. 1 2 Bang, Chul Hwan; Kim, Hei Sung; Park, Young Min; Kim, Hyung Ok; Lee, Jun Young (2011). "Non-familial Acrokeratosis Verruciformis of Hopf". Annals of Dermatology. Korean Dermatological Association and The Korean Society for Investigative Dermatology. 23 (Suppl 1): S61-3. doi:10.5021/ad.2011.23.s1.s61. ISSN   1013-9087. PMC   3199425 . PMID   22028575.
  9. 1 2 Nair, PragyaA (2013). "Acrokeratosis verruciformis of hopf along lines of blaschko". Indian Journal of Dermatology. Medknow. 58 (5): 406. doi: 10.4103/0019-5154.117324 . ISSN   0019-5154. PMC   3778795 . PMID   24082200.
  10. Ormond, Débora Teresa da Silva; Viana, Silvânia Saraiva; Vitral, Érica A. O; Pereira, Carlos Adolpho C; Carvalho, Maria Teresa Feital de (1998). "Acroceratose verruciforme de Hopf: relato de caso". An. Bras. Dermatol (in Portuguese): 25–7. Retrieved 2024-02-26.
  11. Wang, P.-G.; Gao, M.; Lin, G.-S.; Yang, S.; Lin, D.; Liang, Y.-H.; Zhang, G.-L.; Zhu, Y.-G.; Cui, Y.; Zhang, K.-Y.; Huang, W.; Zhang, X.-J. (2006). "Genetic heterogeneity in acrokeratosis verruciformis of Hopf". Clinical and Experimental Dermatology. Oxford University Press (OUP). 31 (4): 558–563. doi:10.1111/j.1365-2230.2006.02134.x. ISSN   0307-6938. PMID   16716163. S2CID   29529897.

Further reading